Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 26;25(Suppl C):C344-C348.
doi: 10.1093/eurheartjsupp/suad031. eCollection 2023 May.

The implantable cardiac monitor in heart failure patient: a possible new indication?

Francesco Cicogna  1 , Oreste Lanza  1 , Luca Monzo  1   2 , Claudia Tota  1 , Gennaro Cice  1 , Ermenegildo De Ruvo  1 , Leonardo Calò  1
Affiliations

The implantable cardiac monitor in heart failure patient: a possible new indication?

Francesco Cicogna et al. Eur Heart J Suppl. .

Abstract

Implantable cardiac monitors (ICMs) have found increasing use in clinical practice over the years, proving, when used in high-risk populations, to facilitate the diagnosis of bradyarrhythmias and tachyarrhythmias requiring treatment. Experience with heart failure patients undergoing pacemaker (PMK) or implantable defibrillator (ICD) implantation, which allow for continuous electrocardiographic monitoring and transthoracic impedance assessment, has made it possible to identify predictors of heart failure flare-ups. In this context, the use of telemonitoring has been shown to ensure better management of patients with heart failure. These benefits cannot be assessed to date in patients with heart failure and left ventricular ejection fraction (LVEF) > 35% who have no indication for PMK or ICD implantation. This population has been shown to have a significant incidence of ventricular arrhythmias and bradyarrhythmias. In addition, a significant number of cerebrovascular events are observed in this population, largely attributable to the high incidence of atrial fibrillation (AF). In this population, the occurrence of AF has also been shown to have a negative impact on patients' prognosis; at the same time, a rhythm control strategy has been shown to be more beneficial in this area than a rate control strategy. Studies also suggest arrhythmias have a negative impact on the cognitive status and quality of life of heart failure patients. These reasons could justify the implantation of ICMs equipped with telemonitoring systems in heart failure patients. The information provided by the monitoring system, if properly managed, could bring benefits in terms of prognosis and quality of life along with a reduction in economic costs. We will try here, by answering a few questions, to assess whether there is an indication for ICM in heart failure, which patients should be candidates and how these patients should be managed.

Keywords: Heart failure; Home monitoring; Implantable cardiac monitor.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None declared.

References

    1. Hawkins NM, Virani SA, Sperrin M, Buchan IE, McMurray JJV, Krahn AD. Predicting heart failure decompensation using cardiac implantable electronic devices: a review of practices and challenges. Eur J Heart Fail 2016;18:977–986. - PubMed
    1. Adamson PB, Abraham WT, Warner Stevenson L, Desai AS, Lindenfeld J, Bourge RCet al. . Pulmonary artery pressure-guided heart failure management reduces 30-day readmissions. Circ Heart Fail 2016;9:e002600. - PubMed
    1. Monzo L, Schiariti M, Calvisi PF, Bonfiglio S, Luštrek M, Puddu PE. Association of patient-reported outcomes and heart rate trends in heart failure: a report from the chiron project. Sci Rep 2020;10:576. - PMC - PubMed
    1. Teerlink JR, Jalaluddin M, Anderson S, Kukin ML, Eichhorn EJ, Francis Het al. . Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death: PROMISE (prospective randomized milrinone survival evaluation) investigators. Circulation 2000;101:40–46. - PubMed
    1. Martino AM, Cicogna F, Palozzi G, Tota C, Monzo L, Mennuni Set al. . Clinical and economic impacts of remote management of heart failure with preserved ejection fraction: preliminary results of a single center experience. Eur J Heart Fail 2020;22:2–415. - PubMed